Executive Profile*

William Meury

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

47$6,365,837

Background*

Mr. William Meury, also known as Bill, has been the Chief Commercial Officer of Allergan plc since May 9, 2016 and served as its Executive Vice President since March 17, 2015 until May 9, 2016. Mr. Meury served as President of Branded Pharma at Allergan plc from March 17, 2015 to May 10, 2016. He served as an Executive Vice President of Commercial - North American Brands at Actavis plc since July 1, 2014. Mr. Meury served as an Executive Vice President of Sales and Marketing ...

Read Full Background

Corporate Headquarters*

909 Third Avenue
New York, New York 10022

United States

Phone: 212-421-7850
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

BS
University of Maryland

Other Affiliations*

Annual Compensation*

Salary$594,231
Total Annual Compensation$594,231

Stock Options*

All Other Compensation$130,981
Exercisable Options111,660
Unexercisable Options39,335
Total Number of Options150,995

Total Compensation*

Total Annual Cash Compensation$6,365,837
Total Short Term Compensation$594,231
Other Long Term Compensation$130,981
Total Calculated Compensation$6,365,837
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Giovanni Caforio M.D.Chief Executive Officer and Director
Bristol-Myers Squibb Company
$1.3M
Mark J. Alles Chief Executive Officer and Director
Celgene Corporation
$871.3K
David A. Ricks Chief Executive Officer, President and Director
Eli Lilly and Company
--
Lars Fruergaard Jørgensen Chief Executive Officer and President
Novo Nordisk A/S
kr8.7M
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.2M GBP
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.